Funny you ask, if you slightly interested in sex and health, you pick up something once and awhile. To much porn do something about your dopamin levels, which again can lead to problems in your normal sex life with a partner.
Yes, there is such a thing as masturbating too much, as well as masturbating with a technique that can affect your level of penile sensitivity during sex. Floating around the internet as “death grip syndrome,” this condition is controversial. Research has found that this may affect penis sensitivity.
https://www.hims.com/blog/6-ways-to-increase-male-sensitivity
Another link with tips
https://www.lybrate.com/topic/when-penis-sensitivity-is-impacted-by-masturbation-1522/f8779e613e82dbd53e561bf3ae303b2e
Because the FDA and drug companies are always right and have your best interest at heart.
From the list of withdrawn drugs. And don't tell me "withdrawn" somehow means the drug companies and FDA were doing their job. There are plenty of poison drugs on the list that Rezulin is on.
========
"Parke-Davis/Warner Lambert submitted the diabetes drug Rezulin for FDA review on July 31, 1996. The medical officer assigned to the review, Dr. John L. Gueriguian, cited Rezulin's potential to harm the liver and the heart, and he questioned its viability in lowering blood sugar for patients with adult-onset diabetes, recommending against the drug's approval. After complaints from the drugmaker, Gueriguian was removed on November 4, 1996, and his review was purged by the FDA.[8][9] Gueriguian and the company had a single meeting at which Gueriguian used "intemperate" language; the company said its objections were based on inappropriate remarks made by Gueriguian.[10] Parke-Davis said at the advisory committee that the risk of liver toxicity was comparable to placebo and that additional data of other studies confirmed this.[11] According to Peter Gøtzsche, when the company provided these additional data one week after approval, they showed a substantially greater risk for liver toxicity.[12] The FDA approved the drug on January 29, 1997, and it appeared in pharmacies in late March. At the time, Dr. Solomon Sobel, a director at the FDA overseeing diabetes drugs, said in a New York Times interview that adverse effects of troglitazone appeared to be rare and relatively mild.[13]" https://en.wikipedia.org/wiki/Troglitazone
Recommended Posts
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now